MEM: Memphasys Limited - Summary | Jitta

Memphasys Limited

AUS:MEM

Price
AU$0.01
Loss Chance
57.9%
1.10JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
106 / 126
961 / 1,065
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (39)
Recent Business Performance (61)
Financial Strength (31)
Return to Shareholders (1)
Competitive Advantage (26)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Cash Conversion CycleLess than 30 days
Operating MarginInconsistent
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
1.10
100.00%
2.66
158.11%
Life Sciences Tools and Services
4.16
98.58%
5.51
114.81%
2.80
100.00%
COMPANY DESCRIPTION
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port, an ambient temperature semen transport device for artificial insemination in animals. In addition, the company develops ambient temperature storage product for human sperm; and a medium for human sperm isolation, fertilisation and cryopreservation. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.